Fig. 1From: Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitisEvolution of patient 3 visual acuity and macular edema on infliximab, subcutaneous (SC) tocilizumab and after the switch for intravenous (IV) tocilizumab. D: day, VA: visual acuityBack to article page